Discordant <i>In Vitro</i> and <i>In Vivo</i> Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts

• Material Type: 記事
• Title: Discordant <i>In Vitro</i> and <i>In Vivo</i> Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts
• Author Heading: Shiv K. Gupta; Ann C. Mladek; Brett L. Carlson; Felix Boakye-Agyeman; Katrina K. Bakken; Sani H. Kizilbash; Mark A. Schroeder; Joel Reid; Jann N. Sarkaria
• Publication Date: 2014-07-14
• Publication Date (W3CDTF): 2014-07-14
• Periodical title: Clinical Cancer Research
• No. or year of volume/issue: 20 14
• Volume: 20
• Issue: 14
• Pages: 3730-3741
• Publication date of volume/issue (W3CDTF): 2014-07-14
• ISSN (Periodical Title): 10780432
• Publication (Periodical Title): American Association for Cancer Research (AACR)
• Target Audience: 一般
• DOI: 10.1158/1078-0432.ccr-13-3446
• Date Created (W3CDTF): 2014-05-17
• Related Material (URI): https://aacrjournals.org/clincancerres/article-pdf/20/14/3730/2019471/3730.pdf
• Is Referenced By: Current trends in mouse models of glioblastoma; https://cir.nii.ac.jp/crid/1360002215417947776; Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells; https://cir.nii.ac.jp/crid/1360013168810998400
• Data Provider (Database): 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• Original Data Provider (Database): Crossref; https://www.crossref.org

• Summary, etc.: <jats:title>Abstract</jats:title> <jats:p>Purpose: Effective sensitizing strategies potentially can extend the benefit of temozolomide ...